BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27611985)

  • 21. Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures.
    Bahçekapılı N; Akgün-Dar K; Albeniz I; Kapucu A; Kandil A; Yağız O; Üzüm G
    Int J Neurosci; 2014 Oct; 124(10):762-70. PubMed ID: 24397543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum neuron-specific enolase and S-100β levels as prognostic follow-up markers for oxygen administered carbon monoxide intoxication cases.
    Yildirim AO; Eroglu M; Kaldirim U; Eyi YE; Simsek K; Durusu M; Yamanel L; Arziman I; Tuncer SK; Toygar M; Balkan A; Cayci T; Demirbas S; Oter S; Bilgi C
    Indian J Biochem Biophys; 2015 Feb; 52(1):29-33. PubMed ID: 26040109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers.
    Olivecrona Z; Bobinski L; Koskinen LO
    Brain Inj; 2015; 29(4):446-54. PubMed ID: 25518864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
    Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
    J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of neuron-specific enolase in head trauma patients.
    Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
    J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury.
    Ning R; Xiong Y; Mahmood A; Zhang Y; Meng Y; Qu C; Chopp M
    Brain Res; 2011 Apr; 1384():140-50. PubMed ID: 21295557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy.
    Dragas M; Koncar I; Opacic D; Ilic N; Maksimovic Z; Markovic M; Ercegovac M; Simic T; Pljesa-Ercegovac M; Davidovic L
    PLoS One; 2015; 10(4):e0124067. PubMed ID: 25859683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human erythropoietin for treating severe traumatic brain injury.
    Bai XF; Gao YK
    Medicine (Baltimore); 2018 Jan; 97(1):e9532. PubMed ID: 29505528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study.
    Joyeux-Faure M; Durand M; Bedague D; Protar D; Incagnoli P; Paris A; Ribuot C; Levy P; Chavanon O
    Fundam Clin Pharmacol; 2012 Dec; 26(6):761-70. PubMed ID: 21929528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
    Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
    Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Oral Glibenclamide on Brain Contusion Volume and Functional Outcome of Patients with Moderate and Severe Traumatic Brain Injuries: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Khalili H; Derakhshan N; Niakan A; Ghaffarpasand F; Salehi M; Eshraghian H; Shakibafard A; Zahabi B
    World Neurosurg; 2017 May; 101():130-136. PubMed ID: 28185976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
    Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM
    J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
    Nichol A; French C; Little L; Presneill J; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R;
    Trials; 2015 Feb; 16():39. PubMed ID: 25884605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Erythropoietin and Stem Cells on Traumatic Brain Injury.
    Tunc Ata M; Turgut G; Akbulut M; Kocyigit A; Karabulut A; Senol H; Turgut S
    World Neurosurg; 2016 May; 89():355-61. PubMed ID: 26850972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers in children with traumatic brain injury].
    Pinelis VG; Sorokina EG; Semenova JB; Karaseva OV; Mescheryakov SV; Chernisheva TA; Arsenieva EN; Roshal LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):66-72. PubMed ID: 26356618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
    Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
    Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum S-100β and NSE levels after off-pump versus on-pump coronary artery bypass graft surgery.
    Zheng L; Fan QM; Wei ZY
    BMC Cardiovasc Disord; 2015 Jul; 15():70. PubMed ID: 26179379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
    Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
    No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O; Solaroglu I; Beskonakli E; Taskin Y
    J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective Effects of Erythropoietin in Patients with Severe Closed Brain Injury.
    Aloizos S; Evodia E; Gourgiotis S; Isaia EC; Seretis C; Baltopoulos GJ
    Turk Neurosurg; 2015; 25(4):552-8. PubMed ID: 26242331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.